<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[takeda Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/takeda.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to takeda]]></description>
	<s:counts start="0" returned="20" found="23" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Takeda's Spree Peaks With Millennium Buy]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100013/takedas-spree-peaks-with-millennium-buy/]]></link>
		<description><![CDATA[The Japanese are coming!    Well, to be exact, one Japanese drugmaker, Takeda Pharmaceutical,  is coming. And the big question is whether its recent buying spree -- capped by its $8.8 billion acquisition of the biotech Millennium Pharmaceuticals announced today -- will leave it looking more like...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 11 Apr 2008 12:53:43 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/velcade.html"><![CDATA[VELCADE]]></category>
		<category domain="http://resources.bnet.com/topic/millennium+pharmaceuticals+inc..html"><![CDATA[Millennium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MLNM</category>
		<category domain="tickers">MLNM</category>
	</item>
	<item>
		<title><![CDATA[Turning Pennies into dollars: (Nasdaq: CEGE), (NASDAQ: ACUS), (OTCBB: XDSL).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200804/ai_n25270491]]></link>
		<description><![CDATA[M2 PRESSWIRE-2 April 2008-RealPennies.com: Turning Pennies into  dollars: (Nasdaq: CEGE), (NASDAQ: ACUS), (OTCBB: XDSL).C1994-2008 M2  COMMUNICATIONS LTD     RDATE:02042008     Are you a public company looking for exposure? Contact  RealPennies.com - 1.800.940.6559     For more info: http://cege.realpennies.com ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/cell+genesys+inc..html"><![CDATA[Cell Genesys Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/mphase+technologies+inc..html"><![CDATA[mPhase Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/processors.html"><![CDATA[Processors]]></category>
		<category domain="http://resources.bnet.com/topic/semiconductors.html"><![CDATA[Semiconductors]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CEGE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XDSL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CEGE,XDSL,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[STHG, CEGE, ACUS, XDSL - OTCStockExchange.com Stock Alert.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200804/ai_n25269923]]></link>
		<description><![CDATA[M2 PRESSWIRE-1 April 2008-otcstockexchange.com: STHG, CEGE, ACUS,  XDSL - OTCStockExchange.com Stock AlertC1994-2008 M2 COMMUNICATIONS  LTD    RDATE:01042008    Rochester, NY -- OTCStockExchange.com's "Stock Watch  Alert" this morning are Steadfast Holdings Group, Inc. (Pink  Sheets: STHG), Cell Genesys, Inc. (Nasdaq: CEGE), Acusphere Inc....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/dsl.html"><![CDATA[DSL]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/mphase+technologies+inc..html"><![CDATA[mPhase Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/processors.html"><![CDATA[Processors]]></category>
		<category domain="http://resources.bnet.com/topic/semiconductors.html"><![CDATA[Semiconductors]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/telecommunications.html"><![CDATA[TELECOMMUNICATIONS]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XDSL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">XDSL,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Feb_4/ai_n24245113]]></link>
		<description><![CDATA[Amgen to Receive $200 Million Upfront Payment, $702 Million in Multi-year Global R&D Expense Sharing and Success-based Milestones, and Double Digit Royalties on Japan Sales; Takeda Will Receive Exclusive Rights to Develop and Commercialize Select Molecules in Japan]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 04 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
	<item>
		<title><![CDATA[Takeda Responds to the FDA Advisory Committee Recommendation.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200707/ai_n23644113]]></link>
		<description><![CDATA[LONDON, July 31 /PRNewswire/ --    LONDON, July 31 /PRNewswire/ --  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 31 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Takeda Responds to the FDA Advisory Committee Recommendation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200707/ai_n19430043]]></link>
		<description><![CDATA[Following a joint meeting today of the U.S. Food and Drug Administration FDA Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development TGRD underscores its position that ACTOS® pioglitazone HCl offers a proven safety profile regarding the risk of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 30 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Takeda Responds to the FDA Advisory Committee Recommendation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_July_30/ai_n27326322]]></link>
		<description><![CDATA[DEERFIELD, Ill. -- Following a joint meeting today of the U.S. Food and Drug Administration FDA Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development TGRD underscores its position that ACTOS([R]) pioglitazone HCl offers a proven safety profile regarding...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 30 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Andrx Corporation Reports Financial Results for 2006 First Quarter]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_May_4/ai_n26852167]]></link>
		<description><![CDATA[FORT LAUDERDALE, Fla. -- Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three months ended March 31, 2006 (the "2006 Quarter"), which are discussed more extensively in Andrx's Form 10-Q for the 2006 Quarter ("March 2006 10-Q") being filed today with the U.S. Securities...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 04 May 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asset.html"><![CDATA[asset]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/income.html"><![CDATA[income]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/merger.html"><![CDATA[merger]]></category>
		<category domain="http://resources.bnet.com/topic/readers.html"><![CDATA[READERS]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/taxes.html"><![CDATA[Taxes]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Takeda Pharmaceutical, Hitachi Jointly Establish New Information]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn6209/is_20060220/ai_n24409048]]></link>
		<description><![CDATA[Tokyo, Feb 20, 2006 - JCN - Takeda Pharmaceutical and Hitachi jointly announced February 20 the establishment of Hitachi Inspharma, Ltd., a joint venture to support and develop information systems for the medical and pharmaceutical industries. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 20 Feb 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/hitachi+ltd..html"><![CDATA[Hitachi Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HIT</category>
		<category domain="tickers">HIT</category>
	</item>
	<item>
		<title><![CDATA[Hitachi, Takeda Pharmaceutical to Establish Information System]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn6209/is_20051007/ai_n24408889]]></link>
		<description><![CDATA[Tokyo, Oct 7, 2005 - JCN - Hitachi and Takeda Pharmaceutical jointly announced on October 3 that the two companies have basically agreed to establish a joint venture company for information system service as of September 29. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 07 Oct 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/hitachi+ltd..html"><![CDATA[Hitachi Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/information+system.html"><![CDATA[information system]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HIT</category>
		<category domain="tickers">HIT</category>
	</item>
	<item>
		<title><![CDATA[Takeda Pharmaceutical Receives FDA Fast Track Designation for TAK-]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn6209/is_20050729/ai_n24408308]]></link>
		<description><![CDATA[Tokyo, July 29, 2005 - JCN - Takeda Pharmaceutical announced on July 27 that one of its US affiliates, Takeda Global Research & Development Center of Illinois, has received fast track designation by the US Food and Drug Administration FDA for TAK-242, its investigational compound designed for the treatment of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 29 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Takeda Pharmaceutical, Wyeth Launches ENBREL Anti-rheumatic Agent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn6209/is_20050331/ai_n24407826]]></link>
		<description><![CDATA[Takeda Pharmaceutical (TSE: 4502) and Wyeth jointly announced on March 29 that they will begin distributing ENBREL, an injection solution for the treatment of rheumatoid arthritis RA, on March 30.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 31 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">WYE</category>
	</item>
	<item>
		<title><![CDATA[3M Pharmaceuticals and Takeda to Collaborate on Potential Treatment for Cervical High-Risk HPV Infection and Cervical Dysplasia]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_March_1/ai_n11834549]]></link>
		<description><![CDATA[ST. PAUL, Minn. & OSAKA, Japan -- 3M and Takeda Pharmaceutical Company Limited Takeda announced today that the two companies entered into an exclusive co-development and joint marketing agreement to collaborate on a potential topical treatment for cervical high-risk human papillomavirus HPV infection and cervical dysplasia.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/3m+co..html"><![CDATA[3M Co.]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MMM</category>
		<category domain="tickers">MMM</category>
	</item>
	<item>
		<title><![CDATA[Kyocera, Osaka Achieve 44%.(Osaka Gas Company Ltd.; electric cogeneration)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5597/is_200412/ai_n23580828]]></link>
		<description><![CDATA[Osaka Gas Co., Ltd. and Kyocera Corp. (6, Takeda Tobadono-cho,  Fushimi-ku, Kyoto, Japan 612-8501; Tel: 075-604-3416) have achieved an  AC output power generation efficiency of 44%, according to operational  assessments conducted by Osaka Gas. Based on   Osaka Gas Co., Ltd. and Kyocera Corp. (6, Takeda...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Dec 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/kyocera+wireless+corp..html"><![CDATA[Kyocera Wireless Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Sumitomo, Takeda form ag chemicals venture. (News).(Japan's largest drug manufacturer forms joint venture with Sumitomo Chemical Company Ltd.)(International Pages)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200208/ai_n13216594]]></link>
		<description><![CDATA[SUMITOMO CHEMICAL Company Ltd. and Takeda Chemical Industries Ltd.  have formed a joint venture in agrochemicals, Sumika Takeda Agrochemical  Company Ltd. The new company will be based in Tokyo and operate as a  joint venture company for five years. S    SUMITOMO CHEMICAL Company Ltd....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 05 Aug 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/chemicals.html"><![CDATA[chemicals]]></category>
		<category domain="http://resources.bnet.com/topic/sumitomo+corp..html"><![CDATA[Sumitomo Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SSUMF</category>
		<category domain="tickers">SSUMF</category>
	</item>
	<item>
		<title><![CDATA[Sumitomo Chemical and Takeda To Form Business Alliance; Takeda To Transfer Its Agrochemicals Business To A New Joint Venture Company]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_July_31/ai_89903314]]></link>
		<description><![CDATA[Business Editors]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 31 Jul 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[alliance]]></category>
		<category domain="http://resources.bnet.com/topic/sumitomo+corp..html"><![CDATA[Sumitomo Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SSUMF</category>
		<category domain="tickers">SSUMF</category>
	</item>
	<item>
		<title><![CDATA[Comparative Analysis 2000. Top 100 Global Chemical Companies.(sales and employees)(Illustration)(Statistical Data Included)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200110/ai_n13211236]]></link>
		<description><![CDATA[Comparative Analysis 2000. Top 100 Global Chemical Companies    All in $m except employees.                                  ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 15 Oct 2001 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/bayer+ag.html"><![CDATA[Bayer AG]]></category>
		<category domain="http://resources.bnet.com/topic/exxon+mobil+corp..html"><![CDATA[Exxon Mobil Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/the+dow+chemical+co..html"><![CDATA[The Dow Chemical Co.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAYR Y</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DOW</category>
		<category domain="tickers">BAYR Y,XOM,DOW</category>
	</item>
	<item>
		<title><![CDATA[BASF and Takeda Combine.(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6621/is_200009/ai_n26340559]]></link>
		<description><![CDATA[BASF Akt, Ludwigshafen, tel:+49 621 60-9 9938, and Takeda Chemical  Industries Ltd, Osaka, Japan, have agreed to combine their bulk vitamins  businesses, which includes transferring part of Takeda's assets.  The agreement has been approved by the respec  BASF Akt, Ludwigshafen, tel:+49 621 60-9 9938, and Takeda...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Sep 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/basf+ag.html"><![CDATA[BASF AG]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BASF Y</category>
		<category domain="tickers">BASF Y</category>
	</item>
	<item>
		<title><![CDATA[BASF Outlines Growth Strategy In Major Markets.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200008/ai_n13311893]]></link>
		<description><![CDATA[The company will focus on health and nutrition following  acquisitions.       BASF POSTED record sales during its fiscal second quarter, mainly  because of the strong performance of its cyclical and commodity  products. But because of a refocusing of    ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 Aug 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/basf+ag.html"><![CDATA[BASF AG]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/income.html"><![CDATA[income]]></category>
		<category domain="http://resources.bnet.com/topic/nutrition.html"><![CDATA[nutrition]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/vitamin.html"><![CDATA[vitamin]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BASF Y</category>
		<category domain="tickers">BASF Y</category>
	</item>
	<item>
		<title><![CDATA[BASF and Takeda to Merge Bulk Vitamins Units.(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200007/ai_n13311665]]></link>
		<description><![CDATA[As PART OF ITS [epsilon]60O million (about $600 million) investment  strategy for its vitamins business, BASF Aktiengesellschaft has signed  an agreement with Takeda Chemical Industries Ltd. to merge their bulk  vitamins businesses in a deal that will    As PART OF ITS [epsilon]60O million (about...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 31 Jul 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/basf+ag.html"><![CDATA[BASF AG]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/vitamin.html"><![CDATA[vitamin]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BASF Y</category>
		<category domain="tickers">BASF Y</category>
	</item>
</channel>
</rss>
